Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Total Liabilities (2023 - 2026)

Updated

Translational Development Acquisition's Total Liabilities came in at $165.05 million for Q2 2026, down 10.5% from $184.35 million a year earlier and down 13.2% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Total Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition's Total Liabilities was $188.24 million, up 4.2% from FY2024.

  • Going back by year, Total Liabilities was $180.6 million in FY2024 and $509,679 in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Total Liabilities since Q4 2023.
  • Business Quant data shows TDACU's Total Liabilities at $190.17 million (Q1 2026), $188.24 million (Q4 2025) and $186.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.05 Mn
Mar 31, 2026 190.17 Mn
Dec 31, 2025 188.24 Mn
Sep 30, 2025 186.36 Mn
Jun 30, 2025 184.35 Mn
Mar 31, 2025 182.54 Mn
Dec 31, 2024 180.60 Mn
Dec 31, 2023 509,679.00
API Access

Translational Development Acquisition Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=TDACU&period=max&api_key=YOUR_API_KEY